Human papillomavirus (HPV) genotypes extended prevalence in the female population from a city in Northern Chile
Implementing a screening program that incorporates extended HPV genotyping in Chile, including testing for high-risk genotypes 16, 18, 31, 39, and 58, is crucial to optimize control, early detection, and vaccination efforts for Chilean circulating HPV genotypes that are not covered by the actual vaccine, thus contributing to a more effective reduction in the burden of disease associated with the virus.
Authors
- Tania Martin (ORCID: https://orcid.org/0009-0003-5843-8873)
- Christian Muñoz (ORCID: https://orcid.org/0000-0003-3959-1269)
- José Antonio Rojas
- Amelia Oleaga Alday
- Karol I. Santoro
- Claudia P. Campillay-Véliz
- Alejandro Catalán (ORCID: https://orcid.org/0000-0002-6886-2489)
- V. Jiménez Escobar
- Jonathan García
- Roylester Araya
- Verónica Callejas
Institutions
- Universidad de Antofagasta (CL)
- University of Concepción (CL)
- Hospital Regional de Antofagasta (CL)
Publication Details
- Journal
- BMC Women s Health
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1186/s12905-025-04179-z
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00